The combination treatment significantly reduced the expressions of p-AKT, p-PI3K, Smad2, Smad3, p-JNK, p-ERK, and NF-κB in tumor tissues, all of which are signaling molecules involved in TGF-β1-induced EMT [211]. The gene discussed is SMAD2; the disease is neoplasm.